Drug Markets/Roflumilast

Roflumilast

33 NDCs across 11 manufacturers|26 Generic,7 Brand

Roflumilast is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Feb 28, 2011, and the first generic was approved Jul 13, 2018. FDA's Orange Book lists 19 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $63 million on Roflumilast across 388,000 claims for 89,000 beneficiaries.

Roflumilast is available as 33 NDCs from 11 manufacturers (26 generic, 7 brand), with NADAC prices from $0.30 to $14.98 per EA — the most expensive product costs about 51× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

33

26G / 7B

Manufacturers

11

competing in market

Price Spread

$0.30 – $14.98

per EA, 30 of 33 NDCs

7d Activity

27↓5 flat

avg -6.1% WoW · of 33 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

33 NDCs total, 33 shown

WatchDrug ↕Price 7d Change ↕
ZORYVE 0.15% CREAM
$15.3852
per GM
-0.07%
ZORYVE 0.3% FOAM
$15.3800
per GM
0.00%
ZORYVE 0.3% CREAM
$15.3781
per GM
-0.04%
DALIRESP 250 MCG TABLET
$14.9826
per EA
—
DALIRESP 250 MCG TABLET
$14.9826
per EA
—
DALIRESP 500 MCG TABLET
$14.9171
per EA
—
DALIRESP 500 MCG TABLET
$14.9171
per EA
—
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 250 MCG TABLET
$1.5343
per EA
-14.98%
ROFLUMILAST 500 MCG TABLET
$0.3204
per EA
—
ROFLUMILAST 500 MCG TABLET
$0.3025
per EA
-2.82%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%
ROFLUMILAST 500 MCG TABLET
$0.2957
per EA
-2.23%

Frequently Asked Questions

What is Roflumilast used to treat?

Roflumilast is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.

When did Roflumilast become available as a generic?

FDA approved the first generic Roflumilast (ANDA) on Jul 13, 2018. The Orange Book currently lists 19 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Roflumilast?

In 2024, Medicare Part D spent $63 million on Roflumilast across 388,000 claims for 89,000 beneficiaries.

How many Roflumilast products are on the market?

The Roflumilast drug market contains 33 NDCs from 11 manufacturers — 26 generic and 7 brand products.

What is the price range for Roflumilast?

NADAC reference prices for Roflumilast range from $0.2957 to $14.9826 per EA — the most expensive product costs about 51× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Roflumilast cheaper than brand?

The average generic NADAC for Roflumilast is $0.7257 per EA, versus $14.9498 for brand-labeled products — brand versions average about 21× the generic price.

Which manufacturers make Roflumilast?

11 manufacturers list Roflumilast in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (5), AstraZeneca Pharmaceuticals LP (4), Camber Pharmaceuticals Inc. (4), Zydus Pharmaceuticals (USA) Inc. (4), Novadoz Pharmaceuticals LLC (4).

How has the price of Roflumilast changed recently?

Over the past 7 days, 0 Roflumilast NDCs rose and 27 fell, with a market-wide average change of -6.1%.